Arcus Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCUS and other ETFs, options, and stocks.About RCUS
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer.
CEOTerry J. Rosen
CEOTerry J. Rosen
Employees627
Employees627
HeadquartersHayward, California
HeadquartersHayward, California
Founded2015
Founded2015
Employees627
Employees627
RCUS Key Statistics
Market cap2.86B
Market cap2.86B
Price-Earnings ratio-6.73
Price-Earnings ratio-6.73
Dividend yield—
Dividend yield—
Average volume2.53M
Average volume2.53M
High today$23.29
High today$23.29
Low today$22.65
Low today$22.65
Open price$23.08
Open price$23.08
Volume690.24K
Volume690.24K
52 Week high$26.40
52 Week high$26.40
52 Week low$6.50
52 Week low$6.50
Stock Snapshot
With a market cap of 2.86B, Arcus Biosciences(RCUS) trades at $23.09. The stock has a price-to-earnings ratio of -6.73.
During the trading session on 2025-12-28, Arcus Biosciences(RCUS) shares reached a daily high of $23.29 and a low of $22.65. At a current price of $23.09, the stock is +1.9% higher than the low and still -0.9% under the high.
Trading volume for Arcus Biosciences(RCUS) stock has reached 690.24K, versus its average volume of 2.53M.
Over the past 52 weeks, Arcus Biosciences(RCUS) stock has traded between a high of $26.40 and a low of $6.50.
Over the past 52 weeks, Arcus Biosciences(RCUS) stock has traded between a high of $26.40 and a low of $6.50.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own RCUS. This list is generated using Robinhood data, and it’s not a recommendation.